Chief Operating Officer (COO)
ExternalPrepare for this interview
EliteAI-generated questions, company research, and talking points tailored to this role
About the role
About Synapticure Founded by patients and caregivers, Synapticure is a mission-driven digital health and life sciences company transforming the care paradigm for millions of individuals and families living with neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS. Through our comprehensive virtual care platform, we provide nationwide, 24/7 access to expert neurologists, cutting-edge therapies, specialized genetic counseling, and wraparound care coordination. We operate as a trusted partner to providers, health plans, and ACOs, including active participation in CMS's landmark GUIDE dementia care model.Our business is powered by a unique, dual-engine ecosystem that bridges clinical scale with groundbreaking life sciences innovation: The CARES Engine (Clinical Operations): The bedrock of our platform is a scalable, 50-state virtualized clinical network. We deliver high-touch, specialized neurology care directly to consumers (DTC) and through strategic B2B integrations with major health systems and payers. By managing the complex medical, behavioral, and logistical needs of both patients and their family caregivers, we improve clinical outcomes, reduce the burden on families, and lower total cost of care. The CURES Engine (Research & Innovation): Leveraging our deeply engaged, well-characterized national patient cohort, the CURES side partners with life science, pharma/biotech, and medical device companies to accelerate the commercialization of neurodegenerative breakthroughs. This division consists of three highly valuable, synergistic capabilities: Discovery-Stage Lab Services: Driven by our proprietary, cutting-edge R&D lab utilizing organoid brain-cell models for specific neurodegenerative conditions to support high-throughput drug candidate screening. Clinical Trial Services: Operating as a full virtual trial and study site for observational, interventional, and Expanded Access Program (EAP) studies, alongside strategic operational partnerships with traditional brick-and-mortar pharma and device/diagnostic sites. Real-World Evidence (RWE) Data & Analytics: Harnessing longitudinal patient journey datasets (including for pharma DTP partners) to provide deep analytical insights to research institutions and commercial developers.
Your Match
How well this role fits your profile.
Company Intel
What employees say
Worked at SynaptiCure Inc.? Share your experience